VUEWAY sol inj 0.5 mmol/ml 3ml en flacon
7680697610015
CH-69761
V08CA12
14.02.0.
Reimbursement limitations:
VUEWAY
VUEWAY est remboursé dans toutes les indications exclusivement à une dose de 0.05 mmol/kg de …
1 / 3
google
Details
- Product number
- 6976101
- CPT
- -
- Packaging group
- 3
- Unit
- ml
- Composition
- gadopiclenolum 481.1 mg corresp. 0.5 mmol corresp. gadolinium 78.6 mg, tetraxetanum, trometamolum, natrii hydroxidum aut acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.46 mg.
Articles (1)
Vueway, Soluzione iniettabile
soluzione
3
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
481.1 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
78.6 MG | Substance | WIIS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.46 MG | Substance | HBESI |
Authorization holder
Bracco Suisse SA
6814 Cadempino
Authorization information
- Swissmedic authorization number
- 69761
- Drug name
- Vueway, Soluzione iniettabile
- Galenic form
- LSINJ
- ATC Code
- V08CA12
- Authorization status
- Z
- Authorization category
- Category C
- Dispensation category
- B
- First authorization
- 28/03/2024
- Authorization expiration date
- 31/12/9999
- IT number
- 14.02.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VUEWAY sol inj 0.5 mmol/ml 3ml en flacon
- Description (DE)
- VUEWAY Inj Lös 0.5 mmol/ml 3ml Durchstechf
- Market launch
- 28/03/2024
- Narcotic (BTM)
- No